Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,503,972
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271,000 K
  • 60-Month Beta 1.20
  • Price/Sales 3.95
  • Price/Cash Flow 5.26
  • Price/Book 1.09
  • Price/Earnings ttm 10.94
  • Earnings Per Share ttm 17.64
  • Most Recent Earnings 5.22 on 02/10/20
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 2.96 (0.00%)
  • Most Recent Dividend 0.740 on 04/15/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.21 +6.52%
on 04/09/20
196.45 -1.75%
on 05/06/20
+11.94 (+6.59%)
since 04/08/20
3-Month
158.67 +21.65%
on 03/18/20
202.21 -4.55%
on 02/12/20
-4.03 (-2.05%)
since 02/07/20
52-Week
114.27 +68.92%
on 06/17/19
202.21 -4.55%
on 02/12/20
+52.97 (+37.82%)
since 05/08/19

Most Recent Stories

More News
Anophthalmia And Microphthalmia Market Research Report 2020-2027: By Product, Application, Manufacturer, Sales and Segmentation

Anophthalmia and microphthalmia mean the absence of an eye and the presence of a small eye within the orbit. Anophthalmia and microphthalmia are interchangeable. Whereas, microphthalmia is a disorder in...

AERI : 13.33 (+2.78%)
AGN : 193.02 (+0.02%)
BAYRY : 17.9800 (+0.45%)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
REGN : 620.86 (-3.09%)
SNPHF : 17.7000 (-4.84%)
VRX.TO : 30.80 (-3.33%)
Viral Gastroenteritis Market 2020 Growth Probability, Key Vendors and Future Scenario Up To 2027

Viral gastroenteritis, also known as stomach flu, is inflammation of the lining of the stomach, small intestine, and large intestine. There are a number of viruses leading viral gastroenteritis such as...

AGN : 193.02 (+0.02%)
BAYRY : 17.9800 (+0.45%)
GSK : 39.91 (-1.14%)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery Market Business Growth Analysis: Crescita Therapeutics Inc., Medpharm, 3M, Bayer AG, Novartis AG

(MENAFN - CDN Newswire) The Topical Drug Delivery Market report includes a range of inhibitors as well as driving forces of the market which are analysed in both qualitative and quantitative approach so...

ABBV : 96.83 (-1.13%)
ACRS : 1.9800 (+10.00%)
AGN : 193.02 (+0.02%)
ATRS : 2.60 (+0.78%)
BAYRY : 17.9800 (+0.45%)
CRRTF : 0.3900 (-4.76%)
HTSUF : 42.0500 (unch)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery Market Business Growth Analysis: Crescita Therapeutics Inc., Medpharm, 3M, Bayer AG, Novartis AG

The report includes a range of inhibitors as well as driving forces of the market which are analysed in both qualitative and quantitative approach so that readers and users get precise information and...

ABBV : 96.83 (-1.13%)
ACRS : 1.9800 (+10.00%)
AGN : 193.02 (+0.02%)
ATRS : 2.60 (+0.78%)
CRRTF : 0.3900 (-4.76%)
HTSUF : 42.0500 (unch)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
VRX.TO : 30.80 (-3.33%)
Ophthalmic Steroids Drug Market Services, Technologies, Future Trends, Company Profiles, Share Analysis, Global Industry Size, Growth Drivers, Regional Scope and Demand Overview 2020-2026

Ophthalmic Steroids Drug Market 2020 Report offers a professional and in-depth study on the current state of the Global Ophthalmic Steroids Drug Market along with competitive landscape, Ophthalmic Steroids...

ALIM : 5.90 (-3.00%)
AGN : 193.02 (+0.02%)
BAYRY : 17.9800 (+0.45%)
GSK : 39.91 (-1.14%)
NVS : 87.01 (-0.38%)
REGN : 620.86 (-3.09%)
VRX.TO : 30.80 (-3.33%)
Bacterial Conjunctivitis Drugs Market Size Study with COVID-19 Impact 2020, Share, Industry Analysis, Growth, Trends, Sales Revenue, Segmentation and Forecast to 2026

AKRX : 0.0900 (-51.01%)
AGN : 193.02 (+0.02%)
BAYRY : 17.9800 (+0.45%)
MRK : 76.73 (+0.05%)
NVS : 87.01 (-0.38%)
PRGO : 55.17 (+1.68%)
PFE : 33.83 (+1.11%)
SNPHF : 17.7000 (-4.84%)
VRX.TO : 30.80 (-3.33%)
Ophthalmoplegia Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2027

Ophthalmoplegia, also referred as extra ocular muscle palsy, is a paralysis of the extra ocular muscles that control movements of eyes. In this condition, nerve fibers that coordinate both eyes in horizontal...

AGN : 193.02 (+0.02%)
NVS : 87.01 (-0.38%)
VRX.TO : 30.80 (-3.33%)
Nystagmus Market Research Report 2020-2027: By Product, Application, Manufacturer, Sales and Segmentation

Nystagmus is a vision associated medical condition, characterized by repetitive and uncontrolled movements of the eye. These movements often result in reduced vision and can further affect the balance...

AERI : 13.33 (+2.78%)
AGN : 193.02 (+0.02%)
BAYRY : 17.9800 (+0.45%)
BMY : 57.43 (-1.17%)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
REGN : 620.86 (-3.09%)
SNPHF : 17.7000 (-4.84%)
VRX.TO : 30.80 (-3.33%)
Neurocutaneous Disorder Market By Development, Trends, Investigation 2020 And Forecast To 2027

The neurocutaneous syndrome is a group of neurologic disorders of brain, spine, and the peripheral nervous system. These diseases are lifelong conditions that may induce a tumor growth inside the skin,...

ABT : 93.04 (-0.67%)
AGN : 193.02 (+0.02%)
MDT : 90.81 (+0.75%)
NVS : 87.01 (-0.38%)
PFE : 33.83 (+1.11%)
SHPG : 179.20 (+4.10%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
Lost Money in Evolus, Inc.?

Evolus, Inc. shares plummeted on July 7, 2020 after the Judge overseeing the International Trade Commission (ITC) case against Evolus and Daewoong reportedly found that the company's Jeuveau wrinkle treatment...

AGN : 193.02 (+0.02%)
EOLS : 3.20 (+5.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AGN with:

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 194.42
1st Resistance Point 193.72
Last Price 193.02
1st Support Level 191.98
2nd Support Level 190.94

See More

52-Week High 202.21
Last Price 193.02
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar